Herbert Mössler

558 total citations
15 papers, 414 citations indexed

About

Herbert Mössler is a scholar working on Neurology, Molecular Biology and Neurology. According to data from OpenAlex, Herbert Mössler has authored 15 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 3 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Herbert Mössler's work include Neurological Disorders and Treatments (14 papers), Neurological Disease Mechanisms and Treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Herbert Mössler is often cited by papers focused on Neurological Disorders and Treatments (14 papers), Neurological Disease Mechanisms and Treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Herbert Mössler collaborates with scholars based in Sweden, Romania and Spain. Herbert Mössler's co-authors include Aruna Sharma, Hari Shanker Sharma, Dafin F. Mureșanu, Preeti K. Menon, José Vicente Lafuente, Ranjana Patnaik, Z. Ryan Tian, Asya Ozkızılcık, Barbara Ruozi and Flavio Forni and has published in prestigious journals such as Progress in brain research, Molecular Neurobiology and International review of neurobiology.

In The Last Decade

Herbert Mössler

15 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert Mössler Sweden 14 217 102 87 78 51 15 414
Preeti K. Menon Sweden 11 171 0.8× 74 0.7× 69 0.8× 74 0.9× 25 0.5× 21 349
Jianing Xi China 12 274 1.3× 75 0.7× 54 0.6× 207 2.7× 25 0.5× 43 694
Vajiheh Aghamollaii Iran 13 83 0.4× 134 1.3× 122 1.4× 128 1.6× 22 0.4× 48 576
Gaigai Li China 14 131 0.6× 116 1.1× 64 0.7× 196 2.5× 15 0.3× 35 633
Andrei Greșiță Romania 12 133 0.6× 24 0.2× 51 0.6× 101 1.3× 20 0.4× 33 413
Meiying Xin China 12 103 0.5× 33 0.3× 32 0.4× 147 1.9× 19 0.4× 21 383
Andrew O. Koob United States 11 93 0.4× 237 2.3× 128 1.5× 112 1.4× 16 0.3× 16 485
Carlos Gómez Canada 9 109 0.5× 17 0.2× 44 0.5× 88 1.1× 24 0.5× 16 493
Dayu Sun China 15 124 0.6× 25 0.2× 95 1.1× 259 3.3× 39 0.8× 29 616
Martina Orečná Slovakia 8 74 0.3× 22 0.2× 43 0.5× 162 2.1× 51 1.0× 11 487

Countries citing papers authored by Herbert Mössler

Since Specialization
Citations

This map shows the geographic impact of Herbert Mössler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Mössler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Mössler more than expected).

Fields of papers citing papers by Herbert Mössler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Mössler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Mössler. The network helps show where Herbert Mössler may publish in the future.

Co-authorship network of co-authors of Herbert Mössler

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Mössler. A scholar is included among the top collaborators of Herbert Mössler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Mössler. Herbert Mössler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ozkızılcık, Asya, Aruna Sharma, José Vicente Lafuente, et al.. (2019). REMOVED: Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease. Progress in brain research. 245. 201–201. 18 indexed citations
2.
Sharma, Aruna, Dafin F. Mureșanu, Asya Ozkızılcık, et al.. (2019). REMOVED: Sleep deprivation exacerbates concussive head injury induced brain pathology: Neuroprotective effects of nanowired delivery of cerebrolysin with α-melanocyte-stimulating hormone. Progress in brain research. 245. 1–1. 19 indexed citations
3.
4.
Sharma, Hari Shanker, Dafin F. Mureșanu, Ala Nozari, et al.. (2019). REMOVED: Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in Alzheimer's disease. Progress in brain research. 245. 145–145. 25 indexed citations
5.
Menon, Preeti K., Aruna Sharma, José Vicente Lafuente, et al.. (2017). REMOVED: Intravenous Administration of Functionalized Magnetic Iron Oxide Nanoparticles Does Not Induce CNS Injury in the Rat: Influence of Spinal Cord Trauma and Cerebrolysin Treatment. International review of neurobiology. 137. 47–47. 23 indexed citations
6.
Ozkızılcık, Asya, Aruna Sharma, Dafin F. Mureșanu, et al.. (2017). Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson’s Disease. Molecular Neurobiology. 55(1). 359–369. 16 indexed citations
7.
Sharma, Aruna, Preeti K. Menon, Ranjana Patnaik, et al.. (2017). REMOVED: Novel Treatment Strategies Using TiO2-Nanowired Delivery of Histaminergic Drugs and Antibodies to Tau With Cerebrolysin for Superior Neuroprotection in the Pathophysiology of Alzheimer's Disease. International review of neurobiology. 137. 123–123. 19 indexed citations
8.
Sharma, Alok, Preeti K. Menon, José Vicente Lafuente, et al.. (2017). Nanodelivery of cerebrolysin reduces functionalized Gold Nanoparticles induced Blood-brain barrier disruption, brain edema formation and brain pathology. 3(2017). 48–51. 1 indexed citations
9.
Ruozi, Barbara, Daniela Belletti, Hari Shanker Sharma, et al.. (2015). PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury. Molecular Neurobiology. 52(2). 899–912. 58 indexed citations
10.
Sharma, Hari Shanker, Preeti K. Menon, José Vicente Lafuente, et al.. (2014). The Role of Functionalized Magnetic Iron Oxide Nanoparticles in the Central Nervous System Injury and Repair: New Potentials for Neuroprotection with Cerebrolysin Therapy. Journal of Nanoscience and Nanotechnology. 14(1). 577–595. 25 indexed citations
11.
Ruozi, Barbara, Daniela Belletti, Flavio Forni, et al.. (2014). Poly (D,L-Lactide-co-Glycolide) Nanoparticles Loaded with Cerebrolysin Display Neuroprotective Activity in a Rat Model of Concussive Head Injury. CNS & Neurological Disorders - Drug Targets. 13(8). 1475–1482. 19 indexed citations
12.
Menon, Preeti K., Dafin F. Mureșanu, Aruna Sharma, Herbert Mössler, & Hari Shanker Sharma. (2012). Cerebrolysin, a Mixture of Neurotrophic Factors Induces Marked Neuroprotection in Spinal Cord Injury Following Intoxication of Engineered Nanoparticles from Metals. CNS & Neurological Disorders - Drug Targets. 11(1). 40–49. 82 indexed citations
13.
Sharma, Hari Shanker, Aruna Sharma, Herbert Mössler, & Dafin F. Mureșanu. (2012). Neuroprotective Effects of Cerebrolysin, A Combination of Different Active Fragments of Neurotrophic Factors And Peptides on the Whole Body Hyperthermia-Induced Neurotoxicity. International review of neurobiology. 102. 249–276. 44 indexed citations
14.
Sharma, Aruna, Dafin F. Mureșanu, Herbert Mössler, & Hari Shanker Sharma. (2012). Superior Neuroprotective Effects of Cerebrolysin in Nanoparticle-Induced Exacerbation of Hyperthermia-Induced Brain Pathology. CNS & Neurological Disorders - Drug Targets. 11(1). 7–25. 30 indexed citations
15.
Rainer, M., et al.. (1997). Therapeutic results with Cerebrolysin in the treatment of dementia.. PubMed. 147(18). 426–31. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Preeti K. Menon Breakdown of academic impact, for papers by Jianing Xi Breakdown of academic impact, for papers by Vajiheh Aghamollaii Breakdown of academic impact, for papers by Gaigai Li Breakdown of academic impact, for papers by Andrei Greșiță Breakdown of academic impact, for papers by Meiying Xin Breakdown of academic impact, for papers by Andrew O. Koob Breakdown of academic impact, for papers by Carlos Gómez Breakdown of academic impact, for papers by Dayu Sun Breakdown of academic impact, for papers by Martina Orečná
Rankless by CCL
2026